Epidermolysis bullosa (EB) is defined as group of phenotipically diverse genodermatoses characterized by blisters and erosions of the skin and mucous membranes. The conditions are genetically and clinically heterogeneous and have a very variable severity spectrum. We present a case of 4 years male child with history of blisters and erosions over hands, feet, knees, elbows, face, lips and oral cavity since birth developing after minimal trauma. These lesions heal without atrophic scars. When the child present to us there was no blisters but healed lesions over both upper and lower limbs with scattered crusted erosions were present. Histology was not done as there was no fresh blister at the time of presentation.

1. Fine JD, Johnson LB, Suchindran C, Moshell A, Gedde-Dahl T, Jr. The epidemiology of inherited epidermolysis bulllosa: Findings in the US, Canadian and European study populations. In: Fine JD, Bauer EA, Mc Guire J, Moshell A, editors. Clinical, epidemiological and laboratory advances, and the findings of the national epidermolysis bullosa registry. Baltimore: John’s Hopkings university press; 1999. p. 101-13.
2. Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008;58:931-50.
3. Horn HM, Priestley GC, Eady RA, Tidman MJ. The prevalence of epidermolysis bullosa in Scotland. Br J Dermatol 1997;136: 560-4.
4. Marinkovich PM, Ortonne JP, Wells MJ, Perry V, Gelfand JM, James WD et al. Epidermolysis Bullosa. http://emedicine.medscape.com/article/1062 939-overview.
5. Mc Grath JA, Mc Millan JR, Dunnil M, Pulkkinen L, Christiano AM, Rodeck CH, et al. Genetic basis of lethal junctional epidermolysis bullosa in an affected fetus: Implications for prenatal diagnosis in one family. Prenat Diagn 1995;15:647-54.
6. Eady RAJ, McGrath JA, McMillan Jr. Ultrastructural genetic disorder of skin: The dermal-epidermal junction. J Invest Dermatol 1994;103:13S-18S.
7. Christiano AM, Uitto J. Molecular complexity of the cutaneous basement membrane zone. Exp Dermatol 1996;5:1-11.
8. Jokman MF, de Jong MC, Heeres K, Pas HH, Vander Meer JB, Owaribe K, et al. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest 1995;95:1345-52.
9. McGrath JA, Ishida-Yamamotoa, O’Grady A, Leigh IM, Eady RA. Structural variation in anchoring fibrils in dystrophic epidermolysis bullosa: Correlation with type VII collagen expression. J Invest Dermatol 1993;100:366-7.
10. Fine J-D. Inherited epidermolysis bullosa. Orphanet Journal of Rare Diseases 2010, 5: 12.
11. Uitto J, Eady R, Fine JD, Feder M, Dart J. The DEBRA International Visioning/ Consensus Meeting on Epidermolysis Bullosa: summary and recommendations. J Invest Dermatol 2000; 114(4): 734-737.
12. Sawamura D, Nakano H, Matsuzaki Y. Overview of epidermolysis bullosa. J Dermatol 2010; 37(3): 214-219.
13. Castiglia D, Zambruno G. Molecular testing in epidermolysis bullosa. Dermatol Clin 2010;28:223-9.
14. Caldwell-Brown D, Stern RS, Lin AN, Carter DM. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. N Engl J Med 1992;327:163-7.
15. Hansen SK, Veien NK. Oxytetracycline in epidermolysis bullosa simplex. A double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol 1996;6:277-8.
16. Langan SM,Williams HC. A systematic review of randomized controlled trials of treatments for inherited forms of epidermolysis bullosa. Clin Exp Dermatol 2008;34:20-5.
17. Featherstone C. Epidermolysis Bullosa: From Fundamental Molecular Biology to Clinical Therapies. J Invest Dermatol 2007;127:256-9.

Ravinder Singh

Medical Officer, Dermatology DR RKGMC Hamirpur H.P India